Skip to content

Investigation of Cigarette Cravings in Smokers

Investigating Stress-Potentiated Memory Updating as a Novel Intervention for Non-Treatment Seeking Smokers

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04843969
Enrollment
76
Registered
2021-04-14
Start date
2018-02-20
Completion date
2022-01-31
Last updated
2021-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Addiction Nicotine, Cigarette Smoking, Tobacco Use

Keywords

Memory updating, Reconsolidation

Brief summary

Interventions to disrupt memory reconsolidation have held promise for the treatment of stress- and anxiety-related disorders. In the present study, the investigators will examine whether an intervention based on these principles, called memory updating, could be adapted for reward-seeking behaviors. To test this, non-treatment seeking tobacco smokers will be exposed to smoking cues and/or stress, two stimuli known to trigger smoking. It is predicted that exposure to a stress task will enhance the cues' motivational salience and yield greater susceptibility to the memory updating procedure. As an add-on, the investigators will examine COVID-associated changes in substance use and whether participants in the memory updating groups might be more resilient to these effects. It is predicted that the changes in substance use will depend on whether the substances are used primarily in social settings.

Detailed description

Non-treatment seeking cigarette dependent smokers will be randomized to one of four testing conditions: 1) a non-stressful task followed by neutral cues, 2) the non-stressful task followed by smoking cues, 3) a stressful task followed by neutral cues, or 4) the stressful task followed by smoking cues. Ten minutes after the intervention, participants will undergo a 60-minute extinction procedure consisting of smoking-related videos, images and smoking paraphernalia. Cue reactivity test sessions will take place 24 hours, 2 weeks and 6 weeks following the intervention. COVID-associated changes in substance use will be quantified over three telephone interviews: one at the end of March / beginning of April 2020 (at the start of the pandemic), one at the end of April / beginning of May, and a final one which will be instituted if feasible once the infection rates and social distancing policies have decreased.

Interventions

Exposure to a psychosocial stressor

BEHAVIORALControl stress exposure

Exposure to a control task (no stress)

BEHAVIORALCue induction

Exposure to a smoking-related task

BEHAVIORALNeutral cue exposure

Exposure to neutral cues

Sponsors

Marco Leyton
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Scoring 5 or higher on the Fagerström Test for Cigarette Dependence * Willingness to abstain from smoking for 4 hours prior to each laboratory visit

Exclusion criteria

* Currently using cigarette cessation products * Endocrinological problems * Significant mental or physical health conditions * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change in cigarettes smoked per day from the pre-intervention baseline to test sessions 2 and 3 given two and six weeks post-interventionAt the end of test session 1 (24 hours post-intervention), participants will receive a journal to record their daily smoking behaviour. They are asked to keep this journal until test session 3 (6 weeks post-intervention).A journal is given to participants to record their cigarette use behaviour every day for a month and a half

Secondary

MeasureTime frameDescription
Change in smoking cue-induced cigarette cravings from the pre-intervention baseline to test session 2Multiple times points during the baseline, intervention and test sessions at 24 hours, 2 weeks and 6 weeks post-intervention.Participants will be asked to complete craving and urge to smoke questionnaires at several time points throughout the study sessions
Change in smoking cue-induced cigarette cravings from the pre-intervention baseline to test session 3Multiple times points during the baseline, intervention and test sessions at 24 hours, 2 weeks and 6 weeks post-intervention.Participants will be asked to complete craving and urge to smoke questionnaires at several time points throughout the study sessions
Change in smoking cue-induced heart rate responses from the pre-intervention baseline to test session 2Multiple time points during the baseline, intervention and test sessions at 24 hours, 2 weeks and 6 weeks post-interventionParticipants' heart rate will be measured through the use of a polar belt at several time points during the study sessions
Change in smoking cue-induced heart rate responses from the pre-intervention baseline to test session 3Multiple time points during the baseline, intervention and test sessions at 24 hours, 2 weeks and 6 weeks post-interventionParticipants' heart rate will be measured through the use of a polar belt at several time points during the study sessions
Change in smoking cue-induced skin conductance responses from the pre-intervention baseline to test session 2Multiple time points during the baseline, intervention and test sessions at 24 hours, 2 weeks and 6 weeks post-interventionParticipants' skin conductance will be measured through the use of electrodes on their index and middle fingers at several time points during the study sessions
Change in tobacco and other substance use patterns from the pre-COVID-19 baseline to post-COVID-19At baseline (before the pandemic) and through study completion, an average of 1 yearParticipants will be asked to report the quantity of cigarettes and/or other substances they have consumed recently
Change in tobacco and other substance use patterns during the COVID-19 pandemic to post-COVID-19Multiple time points during the pandemic and through study completion, an average of 1 yearParticipants will be asked to report the quantity of cigarettes and/or other substances they have consumed recently
Change in smoking cue-induced skin conductance responses from the pre-intervention baseline to test session 3Multiple time points during the baseline, intervention and test sessions at 24 hours, 2 weeks and 6 weeks post-interventionParticipants' skin conductance will be measured through the use of electrodes on their index and middle fingers at several time points during the study sessions
Change in tobacco and other substance use patterns from the pre-COVID-19 baseline to during COVID-19Multiple time points at baseline (before the pandemic), at the start of the pandemic, and during the pandemicParticipants will be asked to report the quantity of cigarettes and/or other substances they have consumed recently

Other

MeasureTime frameDescription
Change in stress- and/or cue-induced mood during the intervention and at test sessions 1, 2 and 3Multiple time points during the intervention and test sessions at 24 hours, 2 weeks and 6 weeks post-interventionParticipants will be asked to complete a mood questionnaire at several time points during the intervention and at test sessions 1, 2 and 3
Change in cigarette use over the course of the procedure as a function of personality factors, childhood trauma, perceived stress, mood and/or cigarette withdrawalMultiple time points at baseline, during the intervention, at test sessions (24 hours, 2 weeks and 6 weeks post-intervention) and telephone follow-ups (6 months post-intervention)Participants will be asked to complete self-report questionnaires about their personality traits, traumatic childhood experiences, perceived stress, current mood states and cigarette withdrawal symptoms

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026